Vertex Pharmaceuticals, Inc. (VRTX)

437.14 +0.55 (+0.13%) USD  |  NASDAQ  |  Apr 22, 15:32
More

Vertex Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Moderna, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade